Men with early-stage prostate cancer who receive androgen deprivation therapy are at significantly higher risk for heart failure, according to a study published in the British Journal of Cancer. After following a cohort of 7,637 men diagnosed with localized prostate cancer between 1998 and 2008, researchers found androgen deprivation therapy was associated with an 81 percent increased risk of heart failure in men without pre-existing cardiovascular disease (CVD).
SOURCE: https://www.cardiovascularbusiness.com/topics/heart-failure/prostate-cancer-treatment-associated-higher-risk-heart-failure?utm_source=CVNW&utm_medium=6c47c50623&utm_content=article&utm_campaign=newsletter_referral